Demuris awarded £204,000 grant funding from Innovate UK

Demuris has secured £204,398 grant funding from Innovate UK to develop new molecular methods for global activation of cryptic biosynthetic gene clusters. Actinobacterial Natural Products are an important source of commercially used compounds, including many clinically used antibiotic, antifungal and anticancer compounds. The genes required to produce these compounds are encoded by Biosynthetic Gene Clusters (BGCs). Genomic …

Demuris awarded £204,000 grant funding from Innovate UK Read More »